| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $17.26 ▲ +1.15% | Yesterday | $16.98 ▼ -0.48% | Tomorrow's Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) setup is anchored to $16.98 and targets $17.26 (+1.15%). The near-term read is upside; watch $17.80 / $16.16 because daily realized volatility is about 5.93%. |
Tomorrow's Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) setup is anchored to $16.98 and targets $17.26 (+1.15%). The near-term read is upside; watch $17.80 / $16.16 because daily realized volatility is about 5.93%. | ||||
| Week | $17.67 ▲ +3.58% | Last Week | $16.80 ▼ -1.50% | The 7-day Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) model moves from $16.80 to $17.67 (+3.58%). It gives upside momentum context for this stock, so breaks around $17.80 / $16.16 matter more than a single tick. |
The 7-day Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) model moves from $16.80 to $17.67 (+3.58%). It gives upside momentum context for this stock, so breaks around $17.80 / $16.16 matter more than a single tick. | ||||
| Month | $18.36 ▲ +7.61% | Last Month | $16.51 ▼ -3.20% | The 1-month Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) target is $18.36 (+7.61%), compared with the live reference near $16.98. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) target is $18.36 (+7.61%), compared with the live reference near $16.98. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $19.39 ▲ +13.67% | Last Year | $16.08 ▼ -5.74% | The 1-year Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) scenario points to $19.39 (+13.67%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) scenario points to $19.39 (+13.67%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $21.81 ▲ +27.86% | 5 Years Ago | $15.06 ▼ -11.70% | The 5-year Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) view is $21.81 (+27.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) view is $21.81 (+27.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| RSI 14 | 50.2 | Neutral |
| MACD | 0.03 | Neutral |
| SMA 50 | $17.34 | Below |
| SMA 200 | $16.86 | Above |
| EMA 20 | $17.01 | Mid |
| Opening Price | $16.98 | Start Date | 2021-05-17 |
| Day Range | $16.33 – $17.63 | Market Cap | $53.69B |
| Monthly Range | $15.34 – $19.67 | 24h Volume | n/a |
| 90D Range | $14.94 – $20.10 | Circulating | n/a |
| 52W Range | $14.08 – $21.80 | Max Supply | n/a |
| TAK | TD | APH | CVX | TJX | MU | |
|---|---|---|---|---|---|---|
| TAK | 1.00 | 0.77 | 0.75 | 0.74 | 0.74 | 0.73 |
| TD | 0.77 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| APH | 0.75 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| CVX | 0.74 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| TJX | 0.74 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| MU | 0.73 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.